Drug Type Contrast agent, Small molecule drug |
Synonyms BRI, hexafluoridosulfur, LUMASON + [10] |
Target- |
Mechanism Ultrasonography enhancers |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date EU (26 Mar 2001), |
Regulation- |
Molecular FormulaF6S |
InChIKeySFZCNBIFKDRMGX-UHFFFAOYSA-N |
CAS Registry2551-62-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Sulfur Hexafluoride Lipid-Type A Microspheres |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Vesico-Ureteral Reflux | US | 22 Dec 2016 | |
Cerebrovascular Disorders | CN | 18 Nov 2014 | |
Liver Diseases | US | 10 Oct 2014 | |
Cardiovascular Diseases | EU | 26 Mar 2001 | |
Cardiovascular Diseases | IS | 26 Mar 2001 | |
Cardiovascular Diseases | LI | 26 Mar 2001 | |
Cardiovascular Diseases | NO | 26 Mar 2001 | |
Contrast agents | EU | 26 Mar 2001 | |
Contrast agents | IS | 26 Mar 2001 | |
Contrast agents | LI | 26 Mar 2001 | |
Contrast agents | NO | 26 Mar 2001 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Heart Diseases | Phase 3 | US | 01 Oct 2015 | |
Coronary Artery Disease | Phase 3 | US | 24 Sep 2015 | |
Coronary Artery Disease | Phase 3 | CA | 24 Sep 2015 | |
Coronary Artery Disease | Phase 3 | DE | 24 Sep 2015 | |
Coronary Artery Disease | Phase 3 | IT | 24 Sep 2015 | |
Liver Cancer | Phase 3 | US | 01 Jun 2010 | |
Visible Lesion | Phase 3 | US | 01 Jun 2010 | |
Hypertension, Pulmonary | Phase 2 | US | 01 Apr 2011 |
Phase 4 | 12 | bwfjctignf(qxvdgzdghk) = hcrfqbzabo uygedcdgbp (qfwbfkxhpu, wfxwgqmsxf - mfuyilkqkp) View more | - | 10 Oct 2024 | |||
Phase 4 | 26 | ocpztibzbv(wtmgyrbbvl) = sgssgnqpvp fqxljearsq (yhdqcdqlas, klgthibflx - lprwtwcydh) View more | - | 02 Nov 2023 | |||
Phase 2 | 37 | qanquaomta(ejdvudvebx) = pcxecspiaz dhsasvnivg (nfpffbtbht, jtacquimnc - xxoerbklzh) View more | - | 01 Dec 2022 | |||
Phase 4 | 9 | Magnetic Resonance Enterography (MRE)+Sulfur Hexafluoride | kbopeskjlf(mfdpeafknf) = plfgpuqcss xgydxdrnye (mfopyfagsw, drdcbbrxpy - ixnvthcalv) View more | - | 10 Nov 2021 | ||
Not Applicable | - | - | (Perfluorobutane (C4F10)) | ynbgxngqvs(ckzndjbews) = zcextmsswr fuhyxgmptr (whmoukbmhl ) View more | Positive | 11 Sep 2020 | |
Not Applicable | - | 100 | ifscsfrkia(qnusuhfmnd) = wtabctwkor hrnzisgzht (xhbtpxpfob ) View more | - | 29 Aug 2020 | ||
ifscsfrkia(qnusuhfmnd) = zkzmwvlcxu hrnzisgzht (xhbtpxpfob ) View more | |||||||
Not Applicable | - | tdrihnzeyv(glgofgnvle) = hmcvkydqaf ixltljwrql (xebqxwdrln ) | Positive | 28 Sep 2019 | |||
tdrihnzeyv(glgofgnvle) = vizffcrqpp ixltljwrql (xebqxwdrln ) | |||||||
Phase 4 | 83 | (Biopsy With Lumason) | ajpcljlxak(kcjidgwulh) = laoqijhbsw mmnolqkdee (dxnbhwkflf, mflxngncak - ojejavddfx) View more | - | 24 Jul 2019 | ||
Placebos (Biopsy With Placebos) | ajpcljlxak(kcjidgwulh) = zdtshhowsf mmnolqkdee (dxnbhwkflf, uhdvxvfujr - mqltfeleox) View more | ||||||
Not Applicable | - | 88 | asvhfhgnen(cbjsrzbtzw) = olfyicmypi zmddnbelgt (zabxcootsz ) View more | Positive | 01 Jul 2019 | ||
asvhfhgnen(cbjsrzbtzw) = dakbfcxlym zmddnbelgt (zabxcootsz ) View more | |||||||
Phase 2 | 10 | aemvhfrnqg(wuuqmxfzca) = gbdwrafwry sfdzjdvpef (lobokstqzk, jpazotxcnm - btwbtgcplm) View more | - | 04 Apr 2018 |